Search results
Ecstasy’s Rebuff as PTSD Therapy Exposes Flawed Processes at FDA
Bloomberg· 5 days agoA federal panel’s near-unanimous opposition to an MDMA-based therapy for post-traumatic stress...
FDA objects to ecstasy for treating PTSD patients
The Washington Times· 5 days agoA nonbinding Food and Drug Administration panel rejected a proposal to use MDMA, or ecstasy, to treat post-traumatic stress disorder. Lykos Therapeutics...
FDA panel rejects ecstasy to treat PTSD
The Week via Yahoo News· 5 days agoLykos' two late-stage trials found vast improvements in a sizable majority of participants who got MDMA, but its data was "uncommonly messy," and the ...
F.D.A. Panel Rejects MDMA-Aided Therapy for PTSD
New York Times· 6 days agoBefore the vote, members of the panel raised concerns about the designs of the two studies submitted by the drug’s sponsor, Lykos Therapeutics. Many...
FDA advisory panel votes against MDMA for treatment of PTSD
PhillyVoice.com· 5 days ago"Participants appear to experience rapid, clinically meaningful, durable...submitted by Lykos...
US expert panel votes against MDMA therapy
BBC via AOL· 6 days agoMDMA - commonly known as ecstasy or molly - has been touted as having therapeutic benefits for people suffering from some mental health disorders. But...
What Is MDMA Therapy and What Are Its Risks?
New York Times· 6 days agoAn F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws. The Food and Drug...
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 10 hours agoIf you're not familiar, MDMA is known by the street names ecstasy or molly, and while still a...
Psychedelic-medicine stocks drop after ecstasy’s rocky day at the FDA
Market Watch· 5 days agoPrivately held Lykos Therapeutics is seeking FDA approval for the treatment combining talk therapy...
Ecstasy as a PTSD treatment gets thumbs down from FDA advisers
Market Watch· 6 days agoOne key issue: Due to the intense effects of MDMA, trial participants and researchers may have a...
